You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Details for New Drug Application (NDA): 087204


✉ Email this page to a colleague

« Back to Dashboard


NDA 087204 describes CROTAN, which is a drug marketed by Legacy Pharma and is included in one NDA. It is available from two suppliers. Additional details are available on the CROTAN profile page.

The generic ingredient in CROTAN is crotamiton. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the crotamiton profile page.
Summary for 087204
Tradename:CROTAN
Applicant:Legacy Pharma
Ingredient:crotamiton
Patents:0
Suppliers and Packaging for NDA: 087204
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CROTAN crotamiton LOTION;TOPICAL 087204 ANDA Marnel Pharmaceuticals, Inc. 0682-0051 0682-0051-10 237 g in 1 BOTTLE, PLASTIC (0682-0051-10)
CROTAN crotamiton LOTION;TOPICAL 087204 ANDA Marnel Pharmaceuticals, Inc. 0682-0051 0682-0051-20 60 g in 1 BOTTLE, PLASTIC (0682-0051-20)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength10%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.